Flucytosine and Anemia

Bennett JE . Flucytosine. Ann Intern Med 1977; 86: 319–22.

Bennett JE . Antifungal agents. In: Mandell GL , Douglas RG , Bennett JE , eds. Principles and practices of infectious diseases. 2nd ed. New York: John Wiley & Sons, 1985: 266–7.

Schonebeck J , Polak A , Fernex M , Scholer HJ . Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. Chemotherapy 1973; 18: 321–36.

Kucers H , Bennett N . The use of antibiotics. London: William Heinemann Medical Books, 1979: 885–97.

Diasio RB , Lakings DE , Bennett JE . Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother 1978; 14: 903–8.

Finn C , Sadee W . Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution mass fragmentography. Cancer Chemother Rep 1975; 59: 279–86.

Koeffler HP , Golde DW . 5-fluorocytosine: inhibition of hematopoiesis in vitro and reversal of inhibition by uracil. J Infect Dis 1979; 139: 438–43.

Wade DN , Sudlow G . The kinetics of 5-fluorocytosine elimination in man. Aust NZ J Med 1972; 2: 153–8.

Kauffman CA , Frame PT . Bone marrow toxicity associated with 5-flucytosine therapy. Antimicrob Agents Chemother 1977; 11: 244–7.

Utz JP , Garrigues IL , Sande MA . Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. Br J Infect Dis 1975; 132: 368–73.

Tester-Dalderup CBM . Antifungal drugs. In: Dukes MNG , ed. Meyler's side effects of drugs. 10th ed. New York: Elsevier, 1984: 517–9.